Skip to main content
Back
Watch Compare

LIFECORE BIOMEDICAL, INC. \DE\

Data quality: 83%
LFCR
Nasdaq Manufacturing Chemicals
$4.72
▲ $0.48 (11.32%)
Mkt Cap: 176.89 M
Price
$4.72
Mkt Cap
176.89 M
Day Range
$4.12 — $4.72
52-Week Range
$3.63 — $8.98
Volume
994,581
Open $4.22
50D / 200D Avg
$6.44
26.65% below
50D / 200D Avg
$7.26
35.03% below

Quick Summary

Key Takeaways

Earnings declined -249.51% over the past year
Generating 7.69 M in free cash flow
ROIC of 2.99% — low return on invested capital
Interest coverage of 0.35× — tight debt servicing

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-249.51%
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC2.99%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio2.80
Interest Coverage0.35

Valuation

PE (TTM)
-15.09
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDA18.61
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -15.1 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

EES logo EES WisdomTree U.S. SmallCap Fund
0.03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -249.51% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11.72 M
ROE N/A ROA -4.96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 7.69 M
ROIC 2.99% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.80
Interest Coverage 0.35 Asset Turnover N/A
Working Capital 53.97 M Tangible Book Value -28.62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15.09 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 18.61 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4.35%
Market Cap 176.89 M Enterprise Value 293.99 M
Per Share
EPS (Diluted TTM) -0.30 Revenue / Share N/A
FCF / Share 0.21 OCF / Share 0.26
EPS CAGR (1Y) -268.75% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -65.64%
SBC-Adj. FCF -3.04 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Revenue — — — — —
Net Income -17.96 M 12.01 M -97.43 M -99.56 M -32.67 M
EPS (Diluted) -0.54 0.32 -3.31 -3.32 -1.12
Gross Profit 23.69 M 41.85 M 50.37 M 27.99 M 81.47 M
Operating Income -733,000.0 -8.84 M -41.29 M -21.80 M -13.50 M
EBITDA — — — — —
R&D Expenses 4.97 M 8.58 M 7.84 M 8.74 M 10.22 M
SG&A Expenses 19.46 M 40.46 M 46.13 M 38.97 M 65.36 M
D&A 8.03 M 8.86 M 17.88 M 13.29 M 19.87 M
Interest Expense 15.85 M — 17.36 M 17.65 M —
Income Tax 337,000.0 183,000.0 -5.84 M 308,000.0 -7.80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Total Assets 232.18 M 253.96 M 295.16 M 253.55 M 502.92 M
Total Liabilities 198.12 M 200.06 M 187.22 M 218.46 M 300.14 M
Shareholders' Equity -14.20 M 11.32 M 107.95 M -4.23 M 202.78 M
Total Debt 142.24 M 101.59 M 98.18 M 84.84 M 164.90 M
Cash & Equivalents 17.47 M 8.46 M 1.64 M 19.09 M 1.30 M
Current Assets 82.29 M 81.03 M 123.71 M 93.88 M 148.32 M
Current Liabilities 23.57 M 38.87 M 79.23 M 39.29 M 101.89 M